RARRES2 and cancer: Evidence supported that chemerin/chemerin1 signaling in the MSCs is relayed via protein kinase C (PKC) and subsequent phosphorylation and activation of protein kinases p42/44, p38 and JnkII, and matrix MMP-2 secretion, which contributes to the trans-endothelial migration of MSCs, potentially contributing to cancer progression [57].